Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
Status:
Recruiting
Trial end date:
2024-06-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability, pharmacokinetics,
pharmacodynamics, and early clinical activity of INCB099280 in participants with select solid
tumors